Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma	gastric mucosa-associated lymphoid tissue lymphoma	Recruiting	Phase 2	2024-02-23		NCT06228963

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fudan University	653

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fudan University Shanghai Cancer Center	Shanghai	China	257

Clinical trials